Skip to content

research on heavy menstrual flow

A Randomized Comparative Study of Safuf ? ?bis and ?ij ?ma bil ? Shar? Versus Placebo and ?ij ?ma bil ? Shar? in Kathrat-i-Hayd (Heavy Menstrual Bleeding) - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/076920
Enrollment
60
Registered
2024-11-18
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N920- Excessive and frequent menstruation with regular cycle

Interventions

Intervention1: Safuf ? ?bis and ?ij ?ma bil ? Shar? (Dry Cupping): 6g of Safuf ? ?bis will be administered orally in the morning for 5 days i.e., from D1 to D5 of the menstrual cycle for 3 consecutive

Sponsors

Government Unani Medical College & Hospital Bangalore-560079
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women both married and unmarried between the age group of 18- 45yrs Women having regular cycles with increase in amount, duration of flow more than 7days or both Patients with pelvic pathology like Uterine fibroid less than 3cms (single or multiple) and Adenomyosis PBAC score more than 100

Exclusion criteria

Exclusion criteria: Patients with Hb less than 7 gm Patients with uncontrolled Diabetes mellitus RBS more than 200mgdl uncontrolled Hypertension BP more than 140/90mmHg Patients with Blood dyscrasias and Malignancy Patients on OCPs and other hormonal therapy

Design outcomes

Primary

MeasureTime frame
Change in Pictorial Blood loss Assessment Chart PBACTimepoint: Before and after menstruation for 3 months One follow up in subsequent cycle

Secondary

MeasureTime frame
Change in Menorrhagia Questionnaire scale for quality of life Change in Hb Timepoint: Before and after menstruation for 3 months with 1 post follow up Hb before and after treatment

Countries

India

Contacts

Public ContactDr Aisha Anjum A

Government Unani Medical College and Hospital

dr.aanjuma@gmail.com8951592300

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026